Abstract
The results of integrated estimations of a complex of lipid indices are presented. Their abnormalities are considered to be atherosclerosis risk factors in the evolution of glomerulonephritis and its different variants, types and stages. The quantitative and qualitative peculiarities of the indicated abnormalities are revealed, in particular, their major expressiveness in chronic form, nephrotic variant and in the stage of renal failure.
Two aspects of correction of actual abnormalities are singled out: 1. indirect, i.e. treatment of the renal pathologic process with preparation of pathogenetic therapy (glucocorticoids, indomethacin), and 2. direct, i.e. with medications exerting a corrective influence on lipid metabolism (clofibrate, nicotinic acid, curantil).
The selection of corrective methods is determined by the stage of disease and by the character of the changes in lipid metabolism.
Similar content being viewed by others
References
Bagdade, J. D.: Mechanism of hyperlipidemia in chronic uremia.Circulation, 52, Suppl. 2, 269 (1975).
Bagdade, J. D.: Effects of clofibrate on plasma lipids and high-density lipoprotein levels in renal allograft recipients.Clin. Nephrol., 12, 85 (1979).
Campanaci, L.: Dislipidemia e aterosclerosis accelerata nell uremia chronica.J. Clin. Med., 59, 318 (1978).
David, K.: Renal disease and hyperlipidemia. IV. Intern. Congr. of Nephrology, Firenze 1975, p. 648.
Giulio, R.: Clofibrate treatment of hyperlipidemia in chronic renal failure.Clin. Nephrol., 8, 504 (1977).
Melman, N. Ya.: Some mechanisms of hyperdyslipidemia in evolution of chronic renal failure and the ways of their correction. Treatment of chronic nephritis. Symposium of Nephrologists of Socialist Countries. Abstracts. 1977, p. 16.
Pyrig, L. A., Melman, N. Ya., Shinkarenko, N. R.: Some indices of lipid metabolism in patients with chronic renal failure under the conditions of systemic hemodialysis.Urologia i nephrologia, 3, 51 (1979).
Pyrig, L. A., Melman, N. Ya., Petrun, N. M.: Medicamental correction of lipid metabolism abnormalities in patients with glomerulonephritis.Klinicheskaya medicina, 2, 49 (1981).
Pyrig, L. A., Melman, N. Ya.: Methodologic basis of glomerulonephritis classification. 18th All-Union Congress of Therapists. Part II. Moscow 1981, p. 439.
Tareev, E. M., Ermolenko, V. M., Nikiforova, N. V.: Fat metabolism abnormality in chronic renal failure.Klinicheskaya medicina, 1, 4 (1976).
Shultsev, G. P., Mutina, E. S.: Alterations of lipid metabolism in some diseases.Therapeuticheskii archiv, 4, 35 (1969).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pyrig, L.A., Melman, N.Y., Petrun, N.M. et al. Abnormalities of lipid metabolism and methods of their correction in patients with glomerulonephritis. International Urology and Nephrology 16, 361–367 (1984). https://doi.org/10.1007/BF02081872
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02081872